Gliquidone
Gliquidone
|
Systematic (IUPAC) name |
---|
N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide |
Clinical data |
---|
AHFS/Drugs.com |
International Drug Names |
---|
|
|
---|
|
|
---|
|
Oral |
---|
Pharmacokinetic data |
---|
Excretion |
95% Biliary, 5% Renal |
---|
Identifiers |
---|
|
33342-05-1 |
---|
|
A10BB08 |
---|
PubChem |
CID 91610 |
---|
DrugBank |
DB01251 Y |
---|
ChemSpider |
82719 Y |
---|
UNII |
C7C2QDD75P Y |
---|
KEGG |
D02430 Y |
---|
ChEMBL |
CHEMBL383634 Y |
---|
Chemical data |
---|
Formula |
C27H33N3O6S |
---|
|
527.634 g/mol |
---|
SMILES
- O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3c(ccc(OC)c3)C(C4=O)(C)C
|
InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
Y
Key:LLJFMFZYVVLQKT-UHFFFAOYSA-N
Y
|
Y (what is this?) (verify) |
---|
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.
|
---|
| Insulin | |
---|
| Other | |
---|
| | | |
---|
| Description |
- Glands
- Hormones
- thyroid
- mineralocorticoids
- Physiology
- Development
|
---|
| Disease |
- Diabetes
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- calcium balance
- corticosteroids
- oral hypoglycemics
- pituitary and hypothalamic
- thyroid
|
---|
|
|